S100B is a Ca2؉ -binding protein of the EF-hand type that is abundantly expressed in astrocytes and has been implicated in the regulation of several intracellular activities, including proliferation and differentiation. We show here that reducing S100B levels in the astrocytoma cell line GL15 and the Müller cell line MIO-M1 by small interference RNA technique results in a rapid disassembly of stress fibers, collapse of F-actin onto the plasma membrane and reduced migration, and acquisition of a stellate shape. Also, S100B-silenced GL15 and MIO-M1 Müller cells show a higher abundance of glial fibrillary acidic protein filaments, which mark differentiated astrocytes, compared with control cells. These effects are dependent on reduced activation of the phosphatidylinositol 3-kinase (PI3K) downstream effectors, Akt and RhoA, and consequently elevated activity of GSK3 and Rac1 and decreased activity of the RhoAassociated kinase. Also, rat primary astrocytes transiently down-regulate S100B expression when exposed to the differentiating agent dibutyryl cyclic AMP and re-express S100B at later stages of dibutyryl cyclic AMP-induced differentiation. Moreover, reducing S100B levels results in a remarkably slow resumption of S100B expression, suggesting the S100B might regulate its own expression. Finally, we show that S100B interacts with Src kinase, thereby stimulating the PI3K/Akt and PI3K/RhoA pathways. These results suggest that S100B might contribute to reduce the differentiation potential of cells of the astrocytic lineage and participate in the astrocyte activation process in the case of brain insult and in invasive properties of glioma cells. S100B, a member of a multigenic family of Ca 2ϩ -binding protein of the EF-hand type, has been implicated in the regulation of both intracellular and extracellular activities (1-3). Within cells, S100B is found diffusely in the cytoplasm and associated with membranes and certain cytoskeleton elements. S100B has been implicated in the regulation of the state of assembly of microtubules and type III intermediate filaments, some enzyme activities, and cell proliferation. This last issue has attracted much attention because levels of S100B are high in certain cancer cells (1, 2, 4), and S100B has been proposed to contribute to tumorigenesis by inhibiting the function of the tumor suppressor protein p53 (5, 6) and to regulate cell proliferation and differentiation by stimulating the activity of the mitogenic kinases Ndr (7) and Akt (protein kinase B) (8).Astrocytes represent the brain cell type with the highest expression of S100B. Levels of S100B are augmented in astrogliosis, and several reports have associated the increased levels of S100B in astrocytes with the pathophysiology of degenerative and infectious/inflammatory brain disorders (1, 2, 9 -11). Moreover, the human S100B gene maps to chromosome 21.q22.3 (12), with consequent high S100B levels in Down syndrome. These observations led to the hypothesis that S100B might be involved in the pathogenesis and/or pathophysiology...